K L Musliner1, F Seifuddin2, J A Judy2, M Pirooznia2, F S Goes2, P P Zandi1. 1. Department of Mental Health,Bloomberg School of Public Health,Johns Hopkins University,Baltimore,MD,USA. 2. Department of Psychiatry and Behavioral Sciences,Johns Hopkins Institute of Medicine,Baltimore,MD,USA.
Abstract
BACKGROUND: Previous studies suggest that the relationship between genetic risk and depression may be moderated by stressful life events (SLEs). The goal of this study was to assess whether SLEs moderate the association between polygenic risk of major depressive disorder (MDD) and depressive symptoms in older adults. METHOD: We used logistic and negative binomial regressions to assess the associations between polygenic risk, SLEs and depressive symptoms in a sample of 8761 participants from the Health and Retirement Study. Polygenic scores were derived from the Psychiatric Genomics Consortium genome-wide association study of MDD. SLEs were operationalized as a dichotomous variable indicating whether participants had experienced at least one stressful event during the previous 2 years. Depressive symptoms were measured using an eight-item Center for Epidemiologic Studies Depression Scale subscale and operationalized as both a dichotomous and a count variable. RESULTS: The odds of reporting four or more depressive symptoms were over twice as high among individuals who experienced at least one SLE (odds ratio 2.19, 95% confidence interval 1.86-2.58). Polygenic scores were significantly associated with depressive symptoms (β = 0.21, p ⩽ 0.0001), although the variance explained was modest (pseudo r 2 = 0.0095). None of the interaction terms for polygenic scores and SLEs was statistically significant. CONCLUSIONS: Polygenic risk and SLEs are robust, independent predictors of depressive symptoms in older adults. Consistent with an additive model, we found no evidence that SLEs moderated the association between common variant polygenic risk and depressive symptoms.
BACKGROUND: Previous studies suggest that the relationship between genetic risk and depression may be moderated by stressful life events (SLEs). The goal of this study was to assess whether SLEs moderate the association between polygenic risk of major depressive disorder (MDD) and depressive symptoms in older adults. METHOD: We used logistic and negative binomial regressions to assess the associations between polygenic risk, SLEs and depressive symptoms in a sample of 8761 participants from the Health and Retirement Study. Polygenic scores were derived from the Psychiatric Genomics Consortium genome-wide association study of MDD. SLEs were operationalized as a dichotomous variable indicating whether participants had experienced at least one stressful event during the previous 2 years. Depressive symptoms were measured using an eight-item Center for Epidemiologic Studies Depression Scale subscale and operationalized as both a dichotomous and a count variable. RESULTS: The odds of reporting four or more depressive symptoms were over twice as high among individuals who experienced at least one SLE (odds ratio 2.19, 95% confidence interval 1.86-2.58). Polygenic scores were significantly associated with depressive symptoms (β = 0.21, p ⩽ 0.0001), although the variance explained was modest (pseudo r 2 = 0.0095). None of the interaction terms for polygenic scores and SLEs was statistically significant. CONCLUSIONS: Polygenic risk and SLEs are robust, independent predictors of depressive symptoms in older adults. Consistent with an additive model, we found no evidence that SLEs moderated the association between common variant polygenic risk and depressive symptoms.
Authors: Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham Journal: Am J Hum Genet Date: 2007-07-25 Impact factor: 11.025
Authors: Marko Elovainio; Markus Jokela; Mika Kivimäki; Laura Pulkki-Råback; Terho Lehtimäki; Nina Airla; Liisa Keltikangas-Järvinen Journal: Psychosom Med Date: 2007-06 Impact factor: 4.312
Authors: Lauren L Mitchell; Rachel Zmora; Jessica M Finlay; Eric Jutkowitz; Joseph E Gaugler Journal: J Gerontol B Psychol Sci Soc Sci Date: 2021-01-01 Impact factor: 4.077
Authors: Anton Schulmann; Euijung Ryu; Vanessa Goncalves; Brandi Rollins; Michael Christiansen; Mark A Frye; Joanna Biernacka; Marquis P Vawter Journal: Mol Neuropsychiatry Date: 2019-02-05
Authors: Erin C Dunn; Anna Wiste; Farid Radmanesh; Lynn M Almli; Stephanie M Gogarten; Tamar Sofer; Jessica D Faul; Sharon L R Kardia; Jennifer A Smith; David R Weir; Wei Zhao; Thomas W Soare; Saira S Mirza; Karin Hek; Henning Tiemeier; Joseph S Goveas; Gloria E Sarto; Beverly M Snively; Marilyn Cornelis; Karestan C Koenen; Peter Kraft; Shaun Purcell; Kerry J Ressler; Jonathan Rosand; Sylvia Wassertheil-Smoller; Jordan W Smoller Journal: Depress Anxiety Date: 2016-04 Impact factor: 6.505
Authors: Lotta-Katrin Pries; Jim van Os; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Maarten Bak; Bochao D Lin; Kristel R van Eijk; Gunter Kenis; Alexander Richards; Michael C O'Donovan; Jurjen J Luykx; Bart P F Rutten; Sinan Guloksuz Journal: JAMA Psychiatry Date: 2020-12-01 Impact factor: 21.596
Authors: A C Edwards; A R Docherty; A Moscati; T B Bigdeli; R E Peterson; B T Webb; S-A Bacanu; J M Hettema; J Flint; K S Kendler Journal: Psychol Med Date: 2017-10-03 Impact factor: 7.723